-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
After acquiring and integrating Tmall Pharmaceuticals, Alipay Healthcare and other related resources, Ali Health's revenue and gross profit have doubled.
November 19, Ali Health announced its 2019 interim results. The announcement showed that for the six months ended September 30, 2018, total revenue was RMB1,879 million and gross profit was RMB529 million, up 111.2% and 107.1% year-on-year, respectively. At the same time, adjusted net profit was $10.5 million. Among them, pharmaceutical self-employed business revenue reached 1.6 billion yuan, an increase of 100.2% year-on-year.Consumer Healthcare's business improved significantly
according to the announcement, Ali Health provided users with an average of more than 1 million medical and health services per day through Alipay, Taobao and other platforms, including payment, registration, online health consulting, etc., while revenue from its consumer healthcare business, including vaccines, oral medicine and medical services, grew 125.1% year-on-year.
fact, Ali Health has proved himself in ali's traditional e-commerce advantage. "The strong growth in revenue and gross margin was mainly due to the rapid growth of the pharmaceutical self-employed business and the pharmaceutical e-commerce platform business during the reporting period," the statement said. According
, pharmaceutical self-employed business revenue reached 1.6 billion yuan, up 100.2% year-on-year. The annual active consumers of the pharmaceutical self-employed business exceed 18 million. During the reporting period, Tmall Pharmaceuticals' total merchandise transactions (GMV) exceeded RMB25 billion, an increase of more than 50% year-on-year. Tmall Pharmaceuticals has more than 100 million active consumers a year.
, Ali Health announced this year's Tmall double 11 performance, including medical examination, medical beauty, oral health care services, including the heat is rising sharply. Opening only 9 hours and 52 minutes, Tmall Medical Museum turnover has exceeded last year's full day; 30 minutes, Tmall Medical Platform turnover is more than last year's full day; 1 hour and 4 minutes, medical services turnover exceeded last year's full day.
interim results announcement shows that as a drug traceability infrastructure of the "code rest assured" platform in the six months to continue to develop steadily, the number of pharmaceutical production enterprises stationed and renewed stable to maintain 80% of the total number of pharmaceutical production enterprises in China, including vaccines and other countries focus on variety coverage of more than 95%.
, Ali Health's ability to pass traceable codes provided users with tools to scan codes and batch numbers for problem vaccines. Not long ago, the State Drug Administration issued "guidance on the construction of drug information traceability system", but also for the "code assured" to further improve coverage provides a policy basis.on November 15th,
Ali Health announced that it had signed a strategic cooperation agreement with Alipay, a subsidiary of Ant Financial Services.
said in a statement, "Ali Health will establish an independent Healthcare Services Channel exclusively on Alipay Client, which will fully manage and operate healthcare industry partners within the channel, while providing users with more comprehensive health care services and products on the Alipay platform through the continuous introduction of new medical institutions and health services." As
flagship platform of Ali's "Double H" strategy in the field of medical and health, Ali Health's integration with Ali's in-house medical business continues uninterrupted.
, Ali Health has gradually completed the acquisition and integration of Tmall Pharmaceuticals.
September 2016, Ali Health announced that the Special General Meeting of Shareholders had approved the service agreement signed between Ali Health and Tmall on August 24, 2016, and that Tmall Pharmaceuticals had been formally included in Ali Health. Ali Health will provide Tmall Pharmaceuticals with a full range of outsourcing and value-added services to assist Tmall in developing its medical and health e-commerce business and charging fees.
fact, there is a high degree of synergy between Tmall Pharmaceuticals and Ali Health. From the model point of view, Tmall Pharmaceuticals has a medical e-commerce traffic entrance, Ali Health is a professional medical service provider. The merger could further upgrade the "Pharmaceutical e-commerce plus medical services" model.
May 2017, Alibaba Health announced that Alibaba Group had injected ali health into Ali Health's online business of Blue Hat, a HK$3.8 billion Tmall medical platform.
In July 2017, in collaboration with Wanliyun, we jointly demonstrated the real-world scenario of human-machine cooperation in remote diagnosis: Ali Health's medical AI "Doctor You" combines medical knowledge and artificial intelligence technology to automatically identify and label suspicious nods, improve doctors' productivity, reduce misdiagnosis and missed appointments, and play a role in "reducing the burden" on doctors.
2017, with Changzhou City, the cooperation of the medical association and blockchain pilot project. Ali Health applies cutting-edge blockchain technology to the underlying technology architecture of the Changzhou Medical Complex and has achieved data connectivity between some local medical institutions. In addition, a strategic cooperation agreement was signed with Xinhua Hospital, affiliated with Shanghai Jiao university school of medicine, to create a model "smart hospital".
2018, Ali Health has significantly increased its cooperation with other business segments of the Ali Department.
April 2018, the "Health Infirmary" was opened in the nail enterprise service market to provide one-stop health solutions such as medical inquiries, drug purchases and medical examinations for enterprise users.
May 2018, Ali Health again announced the acquisition of Tmall Medical Devices and other categories.
September 2018, Ali Health and Alibaba Cloud jointly announced the joint construction of ET Medical Brain 2.0, integrating Ali Medical AI capabilities.
August-October 2018, Ali Health has worked with rookie dot me, hungry hummingbird, in four cities in North Guangshang to achieve a 24-hour emergency delivery service.
Through Ali Health Performance Announcement, we can see that Ali Health is taking pharmaceutical e-commerce and new retail, Internet medical, smart medical, consumer medicine as the main business line, and establishing close cooperation with medical institutions, pharmaceutical manufacturers, pharmaceutical retail enterprises, third-party service providers and other partners to build the "Internet and Pharmaceutical Health" upstream and downstream industry ecology.
continues to increase cooperation with ali system inside and outside, Ali Health has step by step strengthened its position in Alibaba Group's flagship medical and health platform. (Seber Blue)